SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Century Therapeutics, Inc. IPSC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Century Therapeutics, Inc. (IPSC) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 BPMC, CCCC, CGEM, ERAS, EWTX, FIXX 等.

IPSC 的市值为 $205.17M, 而同行平均市值为 $1.91B. IPSC 显著小于其平均同行.

同行与相似公司 — IPSC

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

C4 Therapeutics, Inc.

$2.76 +0.91% $228.6M

Cullinan Oncology, Inc.

$14.35 +0.70% $868.55M

$17.85 +9.44% $5.55B

Edgewise Therapeutics, Inc.

$33.16 -2.01% $3.56B

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

Generation Bio Co.

$5.34 0.00% $35.98M

Monte Rosa Therapeutics, Inc.

$17.50 -0.28% $1.14B

Keros Therapeutics, Inc.

$11.55 +3.59% $429.91M

Kezar Life Sciences, Inc.

$7.36 -0.94% $54.25M

aTyr Pharma, Inc.

$14.69 +2.23% $923.38M

Mineralys Therapeutics, Inc.

$27.32 +0.59% $1.81B

其他人也在看

Blueprint Medicines Corporation

Edgewise Therapeutics, Inc.

Relay Therapeutics, Inc.

Stoke Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

aTyr Pharma, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言